UK MHRA’s approval status on Wockhardt’s Daman facilities continues

13 May 2019 Evaluate

UK MHRA’s approval status on Wockhardt’s manufacturing facilities at Bhimpore and Kadaiya in Daman has been continued.

EudraGMDP database reflects issuance of certificates by UK MHRA stating that the company's manufacturing units at Bhimpore, Daman and Kadaiya, Daman complies with the principles and guidelines of Good Manufacturing Practices of UK MHRA. In view of this, the approval status of the said Units continues.

EudraGMDP is the name of the European Union database which inter-alia contains Good Manufacturing Practice certificates.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1445.75 -12.80 (-0.88%)
02-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1878.00
Dr. Reddys Lab 1373.70
Cipla 1537.55
Lupin 2396.30
Zydus Lifesciences 990.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.